Crk I, also known as v-crk avian sarcoma virus CT10 oncogene homolog, is a signaling adaptor protein that plays a pivotal role in various cellular processes, including growth, differentiation, and migration. This protein is characterized by the presence of an SH2 domain that binds to phosphorylated tyrosine residues and an SH3 domain that interacts with proline-rich sequences. Crk I acts as a molecular scaffold, assembling protein complexes that are essential for the transduction of signals from cell surface receptors to intracellular pathways. Its expression and activity are tightly controlled within the cell, as it is a crucial node in the network of signaling that determines cell fate and function. The modulation of Crk I expression is a complex process that can be influenced by a variety of intracellular signals and extracellular cues, reflecting the dynamic nature of cellular adaptation to environmental changes.
A diverse array of small molecules has been identified that can potentially induce the expression of Crk I, each operating through distinct mechanisms within the cell. For instance, agents such as Phorbol 12-myristate 13-acetate (PMA) are known to activate protein kinase C, which can lead to increased expression of Crk I as part of the cellular response to growth signals. Similarly, compounds like retinoic acid can bind to nuclear receptors, which then interact with DNA to stimulate the transcription of genes, including those governing the expression of Crk I. Other chemicals such as Forskolin act by elevating intracellular cyclic AMP, thereby activating protein kinase A and influencing gene expression profiles. Additionally, epigenetic modifiers like 5-Azacytidine and Trichostatin A may induce Crk I expression by remodeling chromatin structure, making the genomic regions encoding Crk I more accessible for transcription. These molecular mechanisms underscore the intricate web of control that governs Crk I expression, highlighting the sophisticated orchestration of signaling pathways within the cell. Each of these activators operates through a unique pathway, revealing the multifaceted nature of cellular signaling and gene regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, through the activation of protein kinase C, may lead to the upregulation of Crk I expression as it is involved in the control of gene expression and cell proliferation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can induce Crk I expression by interacting with glucocorticoid receptors, which may influence genes involved in cell survival and metabolism. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can stimulate Crk I expression by binding to retinoic acid receptors, which then bind to responsive elements on DNA, affecting gene transcription involved in cell differentiation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can induce Crk I expression potentially by inhibiting glycogen synthase kinase 3, which is implicated in Wnt signaling and thus might affect gene expression related to cell growth. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can stimulate Crk I expression by activating adenylyl cyclase, raising cAMP levels, and thereby activating PKA which can lead to changes in gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may induce Crk I expression by causing DNA demethylation, which can lead to the activation of previously silenced genes, including those involved in cell cycle regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an inhibitor of histone deacetylases, can increase Crk I expression by altering chromatin structure and enabling the transcription of genes involved in cell signaling and apoptosis. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate can upregulate Crk I expression by inhibiting histone deacetylase, which leads to a more open chromatin structure and potentially increases gene transcription. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059, an inhibitor of MEK, may indirectly stimulate Crk I expression by altering the MAPK signaling pathway, which is involved in the regulation of gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580, a p38 MAPK inhibitor, could lead to the upregulation of Crk I expression by modulating stress response pathways and influencing gene transcription. | ||||||